PE20020174A1 - Carboxamidas heterociclicas como agentes antivirales - Google Patents
Carboxamidas heterociclicas como agentes antiviralesInfo
- Publication number
- PE20020174A1 PE20020174A1 PE2001000690A PE2001000690A PE20020174A1 PE 20020174 A1 PE20020174 A1 PE 20020174A1 PE 2001000690 A PE2001000690 A PE 2001000690A PE 2001000690 A PE2001000690 A PE 2001000690A PE 20020174 A1 PE20020174 A1 PE 20020174A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- formula
- antiviral agents
- quinolin
- chlorobenzyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I DONDE X ES Cl, Br, F, CN, NO2; G ES ALQUILO C1-C4 SUSTITUIDO CON OH, NR1R2 O 4-TETRAHIDROPIRANO; R1 ES ALQUILO C2-C7 CON OH, ALCOXILO C1-C4, ARILO; R2 ES H, ALQUILO C1-C7; R1 Y R2 JUNTO A N FORMAN UNA MORFOLINA, PIRROLIDINA; W ES HETEROCICLO DE FORMULA W1, W2, ENTRE OTROS; A ES CR4, N; B ES CR5, N; D ES -(CR13R14)a- DONDE a ES 2-3, -(CR15R16)4-, ENTRE OTROS; CON LA CONDICION DE QUE CUANDO W ES DE FORMULA W1; G ES ALQUILO C1-C4 SATURADO Y SUSTITUIDO POR OH, MORFOLINILO, EN EL CUAL EL MORFOLINILO ESTA UNIDO MEDIANTE EL N; A ES CR4; B ES CR5 Y R8 ES H, ENTONCES AL MENOS UNO DE R13, R14, R7 NO SON H O ALQUILO C1-C7, ENTRE OTRAS CONDICIONES; R4 ES H, HALOGENO, ALQUILO C1-C4; R5 ES H, HALOGENO, OR12 ENTRE OTROS; R7 ES H, ALQUILO C1-C7, ENTRE OTROS; R8 ES H, ALQUILO C1-C7, ENTRE OTROS; R12 ES H, ARILO, HETEROCICLO; R13, R14, R15, R16 SON H, ALQUILO C1-C7, ENTRE OTROS. SON COMPUESTOS PREFERIDOS N-(4-CLOROBENCIL)-8-(4-MORFOLINILMETIL)-6-OXO-6H-IMIDAZO[4,5,1-ij]QUINOLIN-5-CARBOXAMIDA; N-(4-CLOROBENCIL)-8-(3-HIDROXI-1-PROPINIL)-6-OXO-IMIDAZO[4,5,1-ij]QUINOLIN-5-CARBOXAMIDA; ENTRE OTROS. LOS DERIVADOS DE CARBOXAMIDAS HETEROCICLICAS SON AGENTES ANTIVIRALES UTILES PARA EL TRATAMIENTO DE INFECCIONES CAUSADAS POR HERPESVIRUS, VARICELA ZOSTER, CITOMEGALOVIRUS
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21755900P | 2000-07-12 | 2000-07-12 | |
| US27214301P | 2001-02-28 | 2001-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020174A1 true PE20020174A1 (es) | 2002-02-23 |
Family
ID=26912046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001000690A PE20020174A1 (es) | 2000-07-12 | 2001-07-11 | Carboxamidas heterociclicas como agentes antivirales |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6624159B2 (es) |
| EP (1) | EP1299387A1 (es) |
| JP (1) | JP2004502771A (es) |
| AR (1) | AR035188A1 (es) |
| AU (1) | AU2001269699A1 (es) |
| PE (1) | PE20020174A1 (es) |
| WO (1) | WO2002004445A1 (es) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6821969B2 (en) * | 2001-02-13 | 2004-11-23 | Pharmacia & Upjohn Company | Thioxazinoquinolones as antiviral agents |
| EP1458719A1 (en) * | 2001-12-20 | 2004-09-22 | PHARMACIA & UPJOHN COMPANY | Pyridoquinoxaline antivirals |
| JP2005516957A (ja) * | 2001-12-20 | 2005-06-09 | ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー | ピリドキノキサリン抗ウイルス剤 |
| US7745459B2 (en) * | 2004-09-21 | 2010-06-29 | Japan Tobacco Inc. | Quinolizinone compound and use thereof as HIV integrase inhibitor |
| EP1843766A1 (en) * | 2005-01-28 | 2007-10-17 | Merck & Co., Inc. | Antidiabetic bicyclic compounds |
| WO2006120541A1 (en) * | 2005-05-10 | 2006-11-16 | Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. | Ether linked macrolides useful for the treatment of microbial infections |
| AU2008240764C1 (en) * | 2007-04-20 | 2011-10-20 | Glaxo Group Limited | Tricyclic nitrogen containing compounds as antibacterial agents |
| US20110275661A1 (en) * | 2008-10-17 | 2011-11-10 | Glaxo Group Limited | Tricyclic nitrogen compounds used as antibacterials |
| US8975443B2 (en) | 2010-07-16 | 2015-03-10 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
| MX2013000623A (es) | 2010-07-16 | 2013-06-13 | Abbvie Inc | Proceso para la preparación de compuestos antivirales. |
| US9255074B2 (en) | 2010-07-16 | 2016-02-09 | Abbvie Inc. | Process for preparing antiviral compounds |
| WO2012009698A1 (en) | 2010-07-16 | 2012-01-19 | Abbott Laboratories | Phosphine ligands for catalytic reactions |
| ES2628365T3 (es) | 2012-10-16 | 2017-08-02 | Janssen Pharmaceutica N.V. | Moduladores de quinolinilo unidos a fenilo de ROR-GAMA-T |
| WO2014062655A1 (en) | 2012-10-16 | 2014-04-24 | Janssen Pharmaceutica Nv | HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt |
| SG11201502369XA (en) | 2012-10-16 | 2015-05-28 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of ror-gamma-t |
| KR20160068956A (ko) | 2013-10-15 | 2016-06-15 | 얀센 파마슈티카 엔.브이. | RORyT의 퀴놀리닐 조절제 |
| US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
| US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
| US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
| US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
| KR20160070133A (ko) | 2013-10-15 | 2016-06-17 | 얀센 파마슈티카 엔.브이. | RORyt의 알킬 결합 퀴놀리닐 조절제 |
| US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
| WO2016045127A1 (en) | 2014-09-28 | 2016-03-31 | Merck Sharp & Dohme Corp. | Inhibitors of hif prolyl hydroxylase |
| WO2017111076A1 (ja) * | 2015-12-24 | 2017-06-29 | 協和発酵キリン株式会社 | α、β不飽和アミド化合物 |
| CA3031063A1 (en) | 2016-07-29 | 2018-02-01 | Newave Pharmaceutical Inc. | Benzo-quinolizin-2oxo carboxylic acid derivatives for the treatment of hbv infection |
| US11072610B2 (en) | 2018-09-12 | 2021-07-27 | Novartis Ag | Antiviral pyridopyrazinedione compounds |
| CN120842223A (zh) | 2019-09-26 | 2025-10-28 | 诺华股份有限公司 | 抗病毒吡唑并吡啶酮化合物 |
| TWI864587B (zh) * | 2022-02-14 | 2024-12-01 | 美商基利科學股份有限公司 | 抗病毒吡唑并吡啶酮化合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5792774A (en) | 1996-02-21 | 1998-08-11 | Chiroscience Limited | Quinolones and their therapeutic use |
| US6248739B1 (en) | 1999-01-08 | 2001-06-19 | Pharmacia & Upjohn Company | Quinolinecarboxamides as antiviral agents |
| TW500724B (en) | 1999-10-05 | 2002-09-01 | Pharmacia & Amp Upjohn Company | Oxazinoquinolones useful for the treatment of viral infections |
-
2001
- 2001-06-22 US US09/887,578 patent/US6624159B2/en not_active Expired - Fee Related
- 2001-06-25 WO PCT/US2001/016494 patent/WO2002004445A1/en not_active Ceased
- 2001-06-25 JP JP2002509310A patent/JP2004502771A/ja active Pending
- 2001-06-25 EP EP01948226A patent/EP1299387A1/en not_active Withdrawn
- 2001-06-25 AU AU2001269699A patent/AU2001269699A1/en not_active Abandoned
- 2001-07-11 PE PE2001000690A patent/PE20020174A1/es not_active Application Discontinuation
- 2001-07-12 AR ARP010103312A patent/AR035188A1/es not_active Application Discontinuation
-
2003
- 2003-07-31 US US10/631,577 patent/US20040029879A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AR035188A1 (es) | 2004-05-05 |
| EP1299387A1 (en) | 2003-04-09 |
| AU2001269699A1 (en) | 2002-01-21 |
| US20040029879A1 (en) | 2004-02-12 |
| WO2002004445A1 (en) | 2002-01-17 |
| US20020025959A1 (en) | 2002-02-28 |
| JP2004502771A (ja) | 2004-01-29 |
| US6624159B2 (en) | 2003-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20020174A1 (es) | Carboxamidas heterociclicas como agentes antivirales | |
| PE20020143A1 (es) | Carboxamidas heterociclicas como agentes antivirales | |
| EA199900693A1 (ru) | Атропизомеры 3-арил-4(3h)-хиназолинонов и их использование в качестве антагонистов амра-рецепторов | |
| ATE302775T1 (de) | Carbolinderivate | |
| EA200100755A1 (ru) | 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты | |
| AR035885A1 (es) | Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica | |
| PE20020753A1 (es) | Heteroaromaticos fusionados como activadores de la glucoquinasa | |
| AR035548A1 (es) | Compuestos organicos | |
| ATE449099T1 (de) | Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren | |
| ES2190221T3 (es) | Derivados de indol y su uso para el tratamiento de enfermedades malignas y otras, que se basan en proliferaciones celulares patologicas. | |
| CO5590924A2 (es) | Derivados de indolilalquilamina como ligandos de 5- hidroxitriptamina-6 | |
| CA2297326A1 (en) | Heterocyclic compound and antitumor agent containing the same as active component | |
| AR040477A1 (es) | Benzoilureas heterociclicamente sustituidas, procedimiento para su preparacion y su uso como farmacos | |
| DE60129712D1 (de) | Oxazolylaryloxyessigsäure derivate und ihre verwendung als ppar agonisten | |
| CO5590960A2 (es) | Derivados de azaindolilalquilamina como ligandos de 5- hidroxitriptamina-6 | |
| AR006906A1 (es) | Derivados de indazol sustituidos, composiciones farmaceuticas que los contienen, uso de los mismos e intermediarios de sintesis | |
| ATE300543T1 (de) | Kondensierte pyrazindionderivate als pde5 inhibitore | |
| DK1178982T3 (da) | Heterocykliske, substituerede aminoazacykliske forbindelser, der er nyttige som midler til centralnervesystemet | |
| UY29904A1 (es) | Compuestos útiles en terapia | |
| ATE384722T1 (de) | Alkoxypyridinderivate | |
| PE20020974A1 (es) | Quinolincarboxamidas sustituidas como agentes antivirales | |
| ATE439131T1 (de) | Bicyclische verbindungen als hemmer der chemokin- bindung an us28 | |
| AR006189A1 (es) | Aminoalquil-eteres y acilaminoalquil-eteres, procedimiento para su preparacion y su utilizacion como antagonistas de receptores de bradiquinina | |
| ES2052937T3 (es) | Derivados de imidazol sustituido y su procedimiento de preparacion y su utilizacion. | |
| AR015571A1 (es) | Procedimiento para la elaboracion de compuestos derivados de alfa-bromo-lactama y el uso de dichos compuestos para la preparacion de cefalosporinas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FX | Voluntary withdrawal |